Philadelphia, PA, United States of America

Matias Gabriel Hochman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matias Gabriel Hochman: Innovator in Cerebrospinal Fluid Shunt Technology

Introduction

Matias Gabriel Hochman is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical technology, particularly in the area of cerebrospinal fluid (CSF) shunt systems. With a total of 3 patents to his name, Hochman's work focuses on improving the functionality and assessment of CSF shunt systems.

Latest Patents

Hochman's latest patents include a "CSF shunt flow evaluation apparatus and method using a conformable expanded dynamic range thermosensor." This innovative apparatus utilizes thermal dilution to detect a wide range of flow rates and flow status in CSF shunt systems. The design incorporates a large cold source and a specially constructed thermosensor pad, allowing for accurate detection of very low levels of CSF flow. Additionally, the method includes adjustments for varying shunt catheter depths and features a software error check to ensure proper sensor-to-skin contact.

Another significant patent is the "CSF shunt flow enhancer, method for generating CSF flow in shunts and assessment of partial and complete occlusion of CSF shunt systems." This apparatus generates flow in CSF shunt systems by vibrating components or applying cyclical pressure. It provides a quick assessment of shunt patency based on hydraulic resistance, offering a more objective measure of shunt obstruction compared to traditional methods.

Career Highlights

Hochman has worked with several companies, including Shuntcheck, Inc. and Children's Medical Center Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for CSF shunt systems.

Collaborations

Hochman has collaborated with notable individuals in his field, including Marek Swoboda and Mark Evan Mattiucci. These partnerships have likely enhanced his research and development efforts in medical technology.

Conclusion

Matias Gabriel Hochman is a pioneering inventor whose work in cerebrospinal fluid shunt technology has the potential to significantly improve patient outcomes. His innovative patents and collaborations reflect his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…